New Methods for ALK Status Diagnosis in Non–Small-Cell Lung Cancer: An Improved ALK Immunohistochemical Assay and a New, Brightfield, Dual ALK IHC–In Situ Hybridization Assay
Authors:
- 1 August 2013
- journal article
- research article
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 8 (8) , 1019-1031
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- A Dramatic Response to Crizotinib in a Non–Small-Cell Lung Cancer Patient with IHC-Positive and FISH-Negative ALKJournal of Thoracic Oncology, 2012
- A Prospective PCR-Based Screening for the EML4-ALK Oncogene in Non–Small Cell Lung CancerClinical Cancer Research, 2012
- EML4-ALK testing in non-small cell carcinomas of the lung: a review with recommendationsVirchows Archiv, 2012
- Personalized medicine and pharmacogenetic biomarkers: progress in molecular oncology testingExpert Review of Molecular Diagnostics, 2012
- Comparison of Reverse Transcription-Polymerase Chain Reaction, Immunohistochemistry, and Fluorescence In Situ Hybridization Methodologies for Detection of Echinoderm Microtubule-Associated Proteinlike 4–Anaplastic Lymphoma Kinase Fusion–Positive Non–Small Cell Lung Carcinoma: Implications for Optimal Clinical TestingArchives of Pathology & Laboratory Medicine, 2012
- HER2/neu Gene Amplification and Protein Overexpression in Gastric and Gastroesophageal Junction Adenocarcinoma: A Review of Histopathology, Diagnostic Testing, and Clinical ImplicationsArchives of Pathology & Laboratory Medicine, 2012
- ALK-Mutated Non-Small-Cell Lung Cancer: A New Strategy for Cancer TreatmentLung, 2012
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung CancerNew England Journal of Medicine, 2010
- Multiplex Reverse Transcription-PCR Screening for EML4-ALK Fusion TranscriptsClinical Cancer Research, 2008
- Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancerNature, 2007